Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy.
Puebla-Osorio N, Fowlkes NW, Barsoumian HB, Xega K, Srivastava G, Kettlun-Leyton C, Nizzero S, Voss T, Riad TS, Wong C, Huang A, Hu Y, Mitchell J, Kim M, Rafiq Z, He K, Sezen D, Hsu E, Masrorpour F, Maleki A, Leuschner C, Cortez MA, Oertle P, Loparic M, Plodinec M, Markman JL, Welsh JW.
Puebla-Osorio N, et al. Among authors: he k.
Front Oncol. 2024 Oct 9;14:1407143. doi: 10.3389/fonc.2024.1407143. eCollection 2024.
Front Oncol. 2024.
PMID: 39445067
Free PMC article.